Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver

The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aamir Salam Teeli, Kamila Łuczyńska, Effi Haque, Mohmmad Abrar Gayas, Dawid Winiarczyk, Hiroaki Taniguchi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
EMT
Acceso en línea:https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c350
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4a03c20a0c544ba5af6e3277f3e3c350
record_format dspace
spelling oai:doaj.org-article:4a03c20a0c544ba5af6e3277f3e3c3502021-11-11T15:28:57ZDisruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver10.3390/cancers132153572072-6694https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c3502021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5357https://doaj.org/toc/2072-6694The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathologies, such as tumorigenesis. Largely considered tumor suppressants in liver cancer, these transcription factors regulate key events of inflammation, epithelial–mesenchymal transition, metabolic reprogramming, and the differentiation status of the cell. High-throughput analysis of cancer cell genomes has identified a number of hotspot mutations in HNF1α and HNF4α in liver cancer. Such results also showcase HNF1α and HNF4α as important therapeutic targets helping us step into the era of personalized medicine. In this review, we update current findings on the roles of HNF1α and HNF4α in liver cancer development and progression. It covers the molecular mechanisms of HNF1α and HNF4α dysregulation and also highlights the potential of HNF4α as a therapeutic target in liver cancer.Aamir Salam TeeliKamila ŁuczyńskaEffi HaqueMohmmad Abrar GayasDawid WiniarczykHiroaki TaniguchiMDPI AGarticlehepatocellular carcinomaHNF4αHNF1αinflammationβ-cateninEMTNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5357, p 5357 (2021)
institution DOAJ
collection DOAJ
language EN
topic hepatocellular carcinoma
HNF4α
HNF1α
inflammation
β-catenin
EMT
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle hepatocellular carcinoma
HNF4α
HNF1α
inflammation
β-catenin
EMT
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Aamir Salam Teeli
Kamila Łuczyńska
Effi Haque
Mohmmad Abrar Gayas
Dawid Winiarczyk
Hiroaki Taniguchi
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
description The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathologies, such as tumorigenesis. Largely considered tumor suppressants in liver cancer, these transcription factors regulate key events of inflammation, epithelial–mesenchymal transition, metabolic reprogramming, and the differentiation status of the cell. High-throughput analysis of cancer cell genomes has identified a number of hotspot mutations in HNF1α and HNF4α in liver cancer. Such results also showcase HNF1α and HNF4α as important therapeutic targets helping us step into the era of personalized medicine. In this review, we update current findings on the roles of HNF1α and HNF4α in liver cancer development and progression. It covers the molecular mechanisms of HNF1α and HNF4α dysregulation and also highlights the potential of HNF4α as a therapeutic target in liver cancer.
format article
author Aamir Salam Teeli
Kamila Łuczyńska
Effi Haque
Mohmmad Abrar Gayas
Dawid Winiarczyk
Hiroaki Taniguchi
author_facet Aamir Salam Teeli
Kamila Łuczyńska
Effi Haque
Mohmmad Abrar Gayas
Dawid Winiarczyk
Hiroaki Taniguchi
author_sort Aamir Salam Teeli
title Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
title_short Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
title_full Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
title_fullStr Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
title_full_unstemmed Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
title_sort disruption of tumor suppressors hnf4α/hnf1α causes tumorigenesis in liver
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c350
work_keys_str_mv AT aamirsalamteeli disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
AT kamilałuczynska disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
AT effihaque disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
AT mohmmadabrargayas disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
AT dawidwiniarczyk disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
AT hiroakitaniguchi disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver
_version_ 1718435237277466624